Publication | Open Access
Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise
26
Citations
19
References
2017
Year
In this 24-week study, once-daily evogliptin monotherapy significantly improved glycaemic control and was well tolerated in patients with T2D.
| Year | Citations | |
|---|---|---|
Page 1
Page 1